The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast sums of money. But speakers at a MedCity INVEST panel warned that raising more capital than needed is not always… Read More »Investment in healthcare is soaring, but entrepreneurs must be wary of over-capitalizing
Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors. In this instalment, Dominic Tyer is joined by Kinomica CEO Jane Theaker, BioCity investment director Claire Brown, Redx Pharma CEO… Read More »The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget. Sunak is due to make his closely-watched budget speech tomorrow (Wednesday) in the House of Commons, starting from about 12.30. The… Read More »UK chancellor Sunak urged to boost pharma and biotech in budget
Disgraced investor Neil Woodford plans to start a new biotech investment firm as he seeks to capitalise on a booming UK life sciences industry and rebuild his reputation following the collapse of his previous fund. According to press reports, Woodford will be chief investment officer… Read More »Disgraced biotech investor Woodford plans revival as UK biotech booms
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the… Read More »UK biotech investment at record levels amid COVID-19
During a panel discussion at the J.P. Morgan Healthcare Conference, three physicians from Stanford Medicine discussed the investment opportunities that can help accelerate innovation in healthcare in the coming year.
Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.
Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans to expand its portfolio of digital health firms. OTV is the only VC in Israel whose main focus is digital health, specialising in supporting portfolio companies reaching… Read More »Olive Tree Ventures closes $170m dedicated digital health fund
The Florida-based hospital plans to launch the fund next year, under the leadership of a newly named vice president of innovation. It will be used to support startups and invest directly in healthcare companies.
Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. The COVID-19 pandemic… Read More »COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. The companies said the new relationship aims to give patients control over their own digital data so they can be… Read More »Cerner and LRVHealth invest $6m in digital health firm Xealth
Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what’s changed and how they’re working in the midst of the crisis.
Digital health companies once again set a record for funding in 2020, according to a report by Rock Health. They raised a total of $5.4 billion in the first half of the year.